「ja」の検索結果
172件：126～130件目を表示
-
f Licensing Agreement with Brill International Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces that it has entered into...
https://www.senju.co.jp/system/files/content_news/2025-03/ENG_20250307_0.pdf -
f Licensing Agreement with Brill International Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces that it has entered into...
https://www.senju.co.jp/system/files/content_news/2025-03/ENG_20250307.pdf -
maged, leading to progressive visual field loss, and if left untreated, can result in blindness. In Japan, glaucoma is reported to be the leading cause of visual impairment (including reduced vision a...
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904.pdf -
Distribution of Software for Dry-eye Analysis Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distributi...
https://www.senju.co.jp/system/files/content_news/2024-09/ENG_20240906_0.pdf -
maged, leading to progressive visual field loss, and if left untreated, can result in blindness. In Japan, glaucoma is reported to be the leading cause of visual impairment (including reduced vision a...
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904_0.pdf